Public debate surrounding the growth of the biotechnology industry has been dominated by concerns over the ecological and health-related risks of genetically engineered organisms. This article gathers together empirical material from a variety of sources in order to document the adverse social impact of biotech capitalism, both on the integrity and accountability of the scientific community, and on the well-being of the poorer inhabitants of the world. The evidence marshalled here suggests that the shape and use of modern biotechnology is becoming increasingly incompatible with the full development of society's productive resources, and that it reflects instead the political imperative to manufacture commodity-dependent needs at ever-higher levels of abundance.
Get full access to this article
View all access options for this article.
References
1.
Akre, J. (2001) ‘Got Milk? Get Fired: The Inside Story of Censorship at Fox News’, in In These Times, vol. 25, no. 13, 28 May.
2.
Andrews, L. and D. Nelkin (2001) Body Bazaar: The Market for Human Tissue in the Biotechnology Age. Crown, New York.
3.
Barnes, D. E. and L. A. Bero (1998) ‘Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions’, in Journal of the American Medical Association, vol. 279, no. 19, 20 May: 1566–70.
4.
Barnett, A. (2000) ‘Gene scientists disable plants' immune system’, in The Observer, 8 October.
5.
Barnett, A. (2001) ‘Thai fury at US “piracy” of rice gene’, in The Observer, 28 November.
6.
Berlan, J.-P. and R. C. Lewontin (1986) ‘The Political Economy of Hybrid Corn’, in Monthly Review, vol. 38. no. 3, July-August: 35–47
7.
Blumenthal, D., M. Gluck and K. S. Louis et al (1986) ‘University-Industry Research Relationships in Biotechnology: Implications for the Industry’, in Science, vol. 232, no. 4756,13 June: 1361–6.
8.
Blumenthal, D., N. Causino, E. Campbell, K. S. Louis (1996a) ‘Relationships Between Academic Institutions and Industry in the Life Sciences—An Industry Survey’, in New England Journal of Medicine, vol. 334, no. 6, 8 February: 368–73.
9.
Blumenthal, D., E. G. Campbell, N. Causino, K. S. Louis (1996b) ‘Participation of Life-Science Faculty in Research Relations with Industry’, in New England Journal of Medicine, vol. 335, no. 23, 5 December: 1734–9.
10.
Blumethal, D., E. G. Campbell, M. S. Anderson et al (1997) ‘Withholding Research Results in Academic Life Science’, in Journal of the American Medical Association, vol. 277, no. 15, 16 April: 1224–8.
11.
Bonetta, L. (1998) ‘Inquiry into clinical scandal at Canadian research hospital’, in Nature Medicine, vol. 4, no. 10, October: 1095.
12.
Bonetta, L. (1999) ‘Canadian fight over thalassemia drug worsens’, in Nature Medicine, vol. 5, no. 11, November: 1223.
13.
Brown, P. (2001) ‘GM rice promoters “have gone too far”’, in The Guardian, 10 February.
14.
Busch, L., W. B. Lacy, J. Burkhardt and L. R. Lacy (1991) Plants, Power, and Profit: Social, Economic, and Ethical Consequences of the New Biotechnologies. Blackwell, Oxford.
15.
Campbell, E. G., K. S. Louis, D. Blumenthal (1998) ‘Looking a Gift Horse in the Mouth’, in Journal of the American Medical Association, vol. 279, no. 13,1 April: 995–9.
16.
Clapham, J. C., J. R. S. Arch, and H. Chapman, et al (2000) ‘Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean’, in Nature, vol. 406, no. 6794, 27 July: 415–8.
17.
Davidoff, F., C. D. DeAngelis, J. M. Drazen et al (2001) ‘Sponsorship, Authorship, and Accountability’, in New England Journal of Medicine, vol. 345, no. 11,13 September: 825–6.
18.
Dewey, K. G. Dewey (1990). ‘Nutrition and Agricultural Change’, in C. R. Carroll, J. H. Vandermeer and P. Rosset (eds.) Agroecology. McGraw-Hill, New York: 459-80.
19.
Dibb, S. and S. Mayer (2000) ‘The Next Generation of GM Foods: Good for Whose Health?’,Gene Watch, no. 10, April. Text available at: http://www.genewatch.org
20.
ETC (Action Group on Erosion, Technology, and Concentration— formerly RAFI) (2001) ‘Concentration in Corporate Power: The Unmentioned Agenda’, ETC Communiqué, July/August.
21.
Epstein, S. S. (1996) ‘Unlabeled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication’, in International Journal of Health Services, vol. 26, no. 1: 173–85.
22.
Ewen, S. W. B. and A. Pusztai (1999) ‘Effects of diets containing genetically modified potatoes expressingGalanthus nivalislectin on rat small intestine’, in The Lancet, vol. 354, no. 9187,16 October: 1353–4.
23.
Freebairn, D. K. (1995) ‘Did the Green Revolution Concentrate Incomes? A Quantitative Study of Research Reports’, in World Development, vol. 23, no. 2: 265–79.
24.
Frieberg, M., B. Saffran, T. J. Stinson et al (1999) ‘Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology’, in Journal of the American Medical Association, vol. 282, no. 15, 20 October: 1453–7.
25.
Harding, L. (2001) ‘India outraged as US company wins patents on rice’, in The Guardian, 23 August.
26.
Heffernan, B. (1999) ‘Study on Concentration in US Agriculture: Report to the National Farmers Union’, 5 February. Text available at: http://www.greens.org/s-r/gga/heffernan.html
27.
Ho, M.-W. (2001) ‘Killing Fields Near You: Terminator Crops at Large’, in ISIS News, no. 7/8, February. Text available at: www.i-sis.org
28.
Juma, C. (1989) The Gene Hunters: Biotechnology and the Scramble for Seeds. Zed Books, London.
29.
Kimbrell, A. (1997) The Human Body Shop: The Cloning, Engineering, and Marketing of Life. Gateway, Washington.
30.
Kleiner, K. (1994) ‘Milk hormone dispute boils over into court’, in New Scientist, vol. 142, no. 1923,30 April: 6–7.
31.
Kloppenburg, J. R. Jr. (1988) First the Seed: The Political Economy of Plant Biotechnology, 1492-2000. Cambridge University Press, Cambridge.
32.
Kloppenburg, J. R. Jr. and D. L. Kleinman (1988) ‘Seeds of Controversy: National Property Versus Common Heritage’, in J. R. Kloppenburg, Jr. (ed.) Seeds and Sovereignty: The Use and Control of Plant Genetic Resources. Duke University Press, Durham.
33.
Kneen, B. (1999) Farmageddon: Food and the Culture of Biotechnology. New Society Publishers, Gabriola Island.
34.
Krimsky, S., J. G. Ennis, and R. Weissman (1991) ‘Academic-Corporate Ties in Biotechnology: A Quantitative Study’, in Science, Technology, and Human Values, vol. 16, no. 3, Summer: 275–87.
35.
Krimsky, S., L. S. Rothenberg, P. Stott and G. Kyle (1996) ‘Financial Interests of Authors in Scientific Journals: A Pilot Study of 14 Publications’, in Science and Engineering News, vol. 2, no. 4, October: 395–410.
36.
Lappé, F. M. (1991) Diet for a Small Planet. Ballantine, New York.
37.
Lappé, F. M., J. Collins, P. Rosset and L. Esparza (1998) World Hunger: Twelve Myths. Earthscan, London.
38.
Lehrman, S. (1996) ‘Foundations funding biochemical bodies “should shift focus”’, in Nature, vol. 383, no. 6596, 12 September.
39.
Lesser, W. (1998) ‘Intellectual Property Rights and Concentration in Agricultural Biotechnology’, in AgBioForum, vol. 1, no. 2: 56-61. Text available at: http://www.agbioforum.missouri.edu
40.
Lewontin, R. (2001) ‘Genes in the Food!’, in New York Review of Books, vol. 48, no. 10, 21 June.
41.
Lewontin, R. C. and J.-P. Berlan (1990) ‘The Political Economy of Agricultural Research: The Case of Hybrid Corn’, in C. R. Carroll, J. H. Vandermeer and P. Rosset (eds.) Agroecology. McGraw-Hill, New York.
42.
Macalister, T. (2001) ‘Bayer doubles stake in Dolly parent PPL’, in The Guardian, 13 July.
43.
Marx, K. (1970) A Contribution to the Critique of Political Economy. Progress, Moscow.
44.
Mayer, S. (2000) ‘Privatising Knowledge, Patenting Genes: The Race to Control Genetic Information’,Gene Watch, no. 11, June. Text available at: http://www.genewatch.org
45.
Meek, J. (2000a) ‘Patenting our genes’, in The Guardian, 26 June.
46.
Meek, J. (2000b) ‘Why you are first in the great gene race’, in The Guardian, 15 November.
47.
Monbiot, G. (2000) The Captive State: The Corporate Takeover of Britain. Macmillan, London.
48.
Murphy, D. J. (1999) ‘Production of novel oils in plants’, in Current Opinion in Biotechnology, vol. 10, no. 2: 175–80.
49.
Olivieri, N. F, G. M. Brittenham, C. E. McLaren et al (1998) ‘Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major’, in New England Journal Medicine, vol. 339, no. 7, 13 August: 417–23.
50.
Olivieri, N. (1999) ‘Letter to the Editor’, in Nature Medicine, vol. 5, no. 1, January: 3.
51.
Olney, J. W., N. B. Farber, E. Spitznagel and L. N. Robins (1996) ‘Increasing brain tumor rates: is there a link to aspartame?’, in Journal of Neuropathology and Experimental Neurology, vol. 55, no. II, November: 1115–23.
52.
Pretty, J. (2001) ‘Against the grain’, in The Guardian, 17 January.
53.
RAFI (Rural Advancement Foundation International) (1991) ‘Updates: Vanilla and Biotechnology’, RAFi Communiqué, 30 July. RAFI texts available at: www.rafi.org
RAFI (Rural Advancement Foundation International) (2000b) ‘Earmarked for Extinction? Seminis Eliminates 2,000 Varieties’, RAfi Communiqué, 17 July.
58.
RAFI (Rural Advancement Foundation International) (2001a) ‘Bracing for “El Nuna”: Andean Groups Hopping Mad About Popping-Bean Patent’, RAfi News Release, 20 March.
59.
RAFI (Rural Advancement Foundation International) (2001b) ‘Genotypes: Monsanto vs. Percy Schmeiser’, RAfi Communiqué, 2 April.
60.
Rifkin, J. (1999) The Biotech Century: How Genetic Commerce Will Change the World. Pheonix, London.
61.
Roht-Arriaza, N. (1996) ‘Of Seeds and Shamans: The Appropriation of the Scientific and Technical Knowledge of Indigenous and Local Communities’, in Michigan Journal of International Law, vol. 17, Summer: 919–65.
62.
Roht-Arriaza, N. (2000) The Age of Access. Tarcher/Putnam, New York.
63.
Roberts, L. (1992) ‘Anthropologists Climb (Gingerly) on Board’, in Science, vol. 258, no. 5086, 20 November: 1300–1301.
64.
Rosset, P. and Benjamin, M. (eds.) (1994) The Greening of the Revolution: Cuba's Experiment with Organic Agriculture. Ocean Press, Melbourne.
65.
Sexton, S. and Hildyard, N. (1999) ‘Genetic Engineering and World Hunger’, in Synthesis/Regeneration, no. 19, Spring.
66.
Shand, H. (2001) ‘Gene Giants: Understanding the “Life Industry”’, in B. Tokar (ed.) Redesigning Life: the Worldwide Challenge to Genetic Engineering. Zed Books, London.
67.
Sherrid, P. (1998) ‘Please pass the bioengineered butter: DuPont's new push into agricultural biotech’, in U.S. News Online, 2 March. Text available at: http://www.usnews.com
68.
Shiva, V. (1997) Biopiracy: The Plunder of Nature and Knowledge. South End Press, Boston.
69.
Shiva, V. (2000a) Stolen Harvest: The Hijacking of the Global Food Supply. Zed Books, London.
70.
Shiva, V. (2000b) ‘Poverty and Globalisation’, BBC Reith Lectures, May.
71.
Shiva, V. (2000c) ‘The Threat to Third World Farmers’, in The Ecologist, vol. 30, no. 6, September: 40–3.
72.
Shulman, S. (1999) Owning the Future. Houghton Mifflin, New York.
73.
Simms, A. (1999) Selling Suicide: Farming, False Promises, and Genetic Engineering in Developing Countries. Christian Aid, London.
74.
Steinbrecher, R. A. and P. R. Mooney (1998) ‘Terminator technology: the threat to world food security’, in The Ecologist, vol. 28, no. 5, September-October: 276–9.
75.
Stelfox, H. T., G. Chua, K. O'Rourke and A. Detsky (1998) ‘Conflict of Interest in the Debate over Calcium-Channel Antagonists’, in New England Journal of Medicine, vol. 338, no. 2, 8 January: 101–6.
76.
Toenniessen, G. H. (2000) ‘Vitamin A Deficiency and Golden Rice: The Role of the Rockefeller Foundation’, Rockefeller Foundation, 14 November.
77.
Tokar, B. (1998) ‘Monsanto: A Checkered History’, in The Ecologist, vol. 28, no. 5, September/October: 254–61.
78.
Toub, L. (1997) ‘Monsanto's Empire’, in New Internationalist, no. 293, August.
79.
Vidal, J. (2000a) ‘World obese catch up with the underfed’, in The Guardian, 6 March.
80.
Vidal, J. (2000b) ‘Scandal of the food Britain throws away’, in The Guardian, 4 April.
81.
Warwick, H. (2000) Syngenta: Switching off Farmers' Rights. Gene Watch, UK.
82.
Wijk, J. van (1993) ‘Farm seed saving in Europe under pressure’, in Biotechnology and Development Monitor, no. 17, December: 13–14.
